Akebia Therapeutics (AKBA) Reports Q4 Loss of $0.99
Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.99), versus ($0.66) reported last year.
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.
Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.99), versus ($0.66) reported last year.
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.